A REVIEW ON BUCCOADHESIVE TABLET

1. R. Khanna, S. P. Agrawal, A. Ahuja. Mucoadhesive
buccal drug delivery a potential alternative to
conventional therapy, Ind. J. Pharm. Sci. 60 (1): 1-11
(1995).
2. D. Harris, J. R. Robinson. Drug delivery via the
mucous membranes of the oral cavity, J. Pharm. Sci.
81 (1): 1–10 (1992).
3. D. M. Brahmankar, S. B. Jaiswal. Biopharm. &
Pharmacokinetics- A Treatise, Vallabh Prakashan,
New Delhi, 1995, pp. 64-65.
4. D. Harris, J. R. Robinson. Drug delivery via the
mucous membranes of the oral cavity, J. Pharm. Sci.
81 (1): 1–10 (1992).
5. V. H. K. Li, J. R. Robinson, V. H. L. Lee. Influence of
drug properties and routes of drug administration
on the design of sustained and controlled release
system, In: J. R. Robinson and V. H. L. Lee (Eds.),
Controlled drug delivery: fundamental and
applications, Marcel Dekker Inc, New York, 1987 pp.
42-43.
6. T. M. Pramodkumar, K. G. Desai, H. G. Shivakumar.
Mechanism of buccal permeation enhancers, Ind. J.
Pharm. Edu. 36 (3): 147-152 (2002).
7. C. Vijayraghavan, T. K. Ravi. Buccal delivery of
Nifedepine using novel natural mucoadhesive
polymer as an excipients in buccal tablets, Ind.
Drugs 41 (3): 143-148 (2004).
Gaurav et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
731 | P a g e w w w . a r p b . i n f o
8. M. S. Wani, S. R. Parakh, M. H. Dehghan, S. A.
Polshettiwar, V. V. Pande, V. V. Chopade. Current
Status in Buccal Drug Delivery, Pharminfo.net 5 (2):
(2007).
9. M. L. Bruschi, O. D. Freitals. Oral bioadhesive drug
delivery systems, Drug Develop. and Industrial
Pharm. 31 (3): 293-310 (2005).
10. M. I. Juan, M. Huici, M. Konecny, S. Espuelas, M. A.
Campancero, P. Arbos. Bioadhesive properties of
Gantrez nanoparticles, Molecules 10 (1): 126-145
(2005).
11. A. P. Sam, J. T. V. D. Heuij, J. Tukker. Mucoadhesion
of both film-forming and non- film forming
polymeric materials as evaluated with the Wilhelmy
plate method, Int. J. Pharm. 53: 97-105 (1989).
12. E. E. Hassan, J. M. Gallo. Simple rheological method
for the in vitro assessment of mucin polymer
bioadhesive bond strength, Pharm. Res. 7 (5): 491-
498 (1990).
13. N. S. Miller, T. P. Johnston. The use of mucoadhesive
polymers in buccal drug delivery, Adv. drug delivery
Rev. 57 (11): 1666-1691 (2005).
14. S. Velmurugan. Formulation and in-vitro evaluation
of losartan potassium mucoadhesive buccal tablet,
Asian J. Pharm. Clin. Res. 6 (3): 125-130 (2013).
15. S. B. Shirsand, G. V. Wadageri, S. A. Raju, G. Kolli and
P. V. P. Reddy. Design and evaluation of
mucoadhesive bilayer buccal tablets of nebivolol,
RGUHS J. Pharm. Sci. 3 (1): 40-47 (2013).
16. K. Gowthamarajan, N. Jawahar, P. Wake, K. Jain, S.
Sood. Development of buccal tablets for curcumin
using Anacardium occidentale gum, Carbohydrate
Polymers 88 (4):1177–1183 (2012).
17. K. A. Reddy and K. Venugopal. Formulation and invitro
evaluation of buccal tablets of piroxicam, Int. J.
Chem. Sci. 10 (1): 399-312 (2012).
18. P. S. Kumar, B. Srikanth, T. Satyanarayana, G. Shaji,
S. N. Krishnan, P. Saranya. Formulation and
evaluation of nabivolol mucoadhesive buccal tablet,
Pharmacologyonline 3: 869-885 (2011).
19. K. N. Raju, S. Velmurugan, B. Deepika, S. Vinusitha.
Formulation and in-vitro evaluation of buccal
tablets of metoprolol tartrate, Int. J. Pharm. Pharm.
Sci. 3 (2): 239-246 (2011).
20. B. A. Goud, K. S. Swamy, and V. P. Kumar.
Formulation and evaluation of bioadhesive buccal
tablets of simvastatin, J. Adv. Pharm. Sci. 1 (1): 29-
38 (2011).
21. H. Boyapally, R. K. Nukala, P. Bhujbal, D. Douroumis.
Controlled release from directly compressible
theophylline buccal tablet, Colloids and Surfaces B:
Biointerfaces 77 (2): 227–233 (2010).
22. S. B. Bhanja, P. Ellaiah, S. K. Martha, P. K. Sahu, S. P.
Tiwari, B. B. Panigrahi, D. Das. Design and
evaluation of timolol maleate mucoadhesive buccal
tablets, Int. J. Pharm. & Health Sci. 1 (4): 100-108
(2010).
23. G. Aditya, G. K. Gudas, M. Bingi, S. Debnath, V. V.
Rajesham. Design and evaluation of controlled
release mucoadhesive buccal tablets of lisinopril,
Int. J. Curr. Pharm. Res. 2 (4): 24-27 (2010).
24. S. Velmurugan, B. Deepika, K. Nagaraju, S.
Vinushitha. Formulation and in-vitro evaluation of
buccal tablets of piroxicam, Int. J. Pharm. Tech. Res.
2 (3): 1958-1968 (2010).
25. S. B. Bhanja, P. Ellaiah, S. K. Martha, P. K. Sahu, S. P.
Tiwari, B. B. Panigrahi, D. Das. Design and
evaluation of timolol maleate mucoadhesive buccal
tablets, Int. J. Pharm. & Health Sci. 1 (4): 100-08
(2010).
26. D. Mahalaxmi, A. Senthil, V. Prasad, B. Sudhakar, S.
Mohideen. Formulation and evaluation of
mucoadhesive buccal tablets of glipizide, Int. J.
Biopharm. 1 (2): 100-107 (2010).
27. R. Manivannan, A. Balasubramaniam, D. C. Prem
Anand, G. Sandeep, and N. Rajkumar. Formulation
and in-vitro evaluation of mucoadhesive buccal
tablets of diltiazem hydrochloride, Res. J. Pharm.
and Tech. 1 (4): 478-480 (2008).
28. L. I. Giannola, V. D. Caro, G. Giandalia, M. G. Siragusa,
C. Tripodo, A. M. Florena, G. Campisi. Release of
naltrexone on buccal mucosa: Permeation studies,
histological aspects and matrix system design, Eur.
J. of Pharm. and Biopharm. 67 (2): 425–33 (2007).
29. S. M. Samani, R. B. Najafi, G. Yousefi. Formulation
and in vitro evaluation of prednisolone
buccoadhesive tablets, II Farmaco 60 (4): 339–344
(2005).
30. G. Ikinci, S. Senel, C. G. Wilson, M. Sumnu.
Development of a buccal bioadhesive nicotine tablet
formulation for smoking cessation, Int. J. Pharm.
277 (1-2):173–178 (2004).
31. P. Luana, A. Valeria, R. Daniela, G. Stefano, R.
Maurizio, B. Paolo, R. Carlo. Novel mucoadhesive
buccal formulation containing metronidazole for
the treatment of periodontal disease, J. Contr. Rel.
95 (3): 521–533 (2004).
32. J. Varshosaz, Z. Dehghan. Development and
characterization of buccoadhesive nifedipine
tablets, Eur. J. Pharm. and Biopharm. 54 (2): 135–
141 (2002).
33. P. Giunchedia, C. Julianoa, E. Gavinia, M. Cossua, M.
Sorrenti. Formulation and in vivo evaluation of
chlorhexidine buccal tablets prepared using drugGaurav
et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
732 | P a g e w w w . a r p b . i n f o
loaded chitosan microspheres, Eur. J. Pharm. and
Biopharm. 53 (2): 233–239 (2002).
34. H. G. Choia, C. K. Kim. Development of omeprazole
buccal adhesive tablets with stability enhancement
in human saliva, J. Cont. Rel. 68 (2): 397-404
(2000).
35. C. H. Gon, J. J. Hee, S. Y. Chul, R. C. Dal, L. M. Kyung, H.
J. Hee, M. P. Kyung, K. K. Chong. Formulation and in
vivo evaluation of omeprazole buccal adhesive
tablet, J. Contr. Rel. 68 (3): 405–412 (2000).
36. S. H. Alur, I. Pather, A. K. Mitra, T. P. Johnston.
Transmucosal sustained delivery of
chlorpheniramine maleate in rabbits using a novel,
natural mucoadhesive gum as an excipient in buccal
tablets, Int. J. Pharm. 188 (1): 1–10 (1999).
37. B. Taylan, Y. Capan, O. Gtiven, S. Kes, A. A. Hincal.
Design and evaluation of sustained-release and
buccal adhesive propranolol hydrochloride tablets,
J. Contr. Rel. 38 (1): 11-20 (1996).
38. R. Khanna, S. P. Agarwal, A. Ahuja. Preparation and
evaluation of bioerodible buccal tablet containing
clotrimazole, Int. J. Pharm. 138 (1): 67-73 (1996).
39. V. Path, G. Ming, Y. Bo, L. Wei, Z. Qiuxiang, G.
Tingting. Compound buccal adhesive tablet
containing triamcinolone acetonide and preparation
method thereof, C. N. Patent CN103494827 A, 2014.
40. L. Was. Chilli buccal tablet, Preparation method
thereof and application, C. N. Patent CN 103300334
A, 2013.
41. C. Zhuen, B. Xing. Dendrobium Panax quinquefolius
buccal tablet and its preparation method, C. N.
Patent CN 103285240 A, 2013.
42. X. Zhang, L. Xu, Y. Zhou. Stewed tendon buccal
tablets and preparation method method thereof, C.
N. Patent CN 102187998 B, 2013.
43. G. Thomas, L. Ralf, A. A. M. Abdul. Buccal application
system comprising 17a-estradio, U. S. Patent US
20120142656 A1, 2012.
44. A. Pierre, C. Dominique, L. Caroline. Mucoadhesive
buccal tablets for the treatment of orofacial herpes,
U. S. Patent US 8592434 B2, 2011.
45. L. Hongquan, L. Mousheng, Y. Yaling, Z.Yin.
Smallanthus sonchifolius buccal tablet and
preparation method thereof, C. N. Patent CN
101569645 A, 2009.
46. P. B. Foreman, Y. Zhang, R. Puri. Mucosal delivery
tablet, E. P. Patent EP 1757267 A2, 2007.
47. A. N. Rongala, D. M. Parvataneni, P. Khadgapathi, V.
C. Nannapaneni. Controlled release mucoadhesive
matrix formulation containing tolterodine and a
process for its preparation, W. O. Patent WO
2005105036 A1, 2005.
48. D. F. Bain, D. Munday, C. Park, O. Shakoor. Bilayered
buccal tablets comprising nicotine, W. O. Patent WO
2001037814 A1, 2001.
49. I. Rault. Bioadhesive tablets, U. S. Patent US
6242004 B1, 2011.
50. W. J. Bologna, P. Cartier, Z. D. De, H. L. Levine.
Extended release buccal bioadhesive tablet, W. O.
Patent WO 2000010536 A1, 2000.
51. M. S. Balkin. Oral transmucosal delivery tablet and
method of making it, U. S. Patent US 5656284 A,
1997.
52. J. A. McCarty. Rapid drug delivery by mouth
administering a tablet with a lubricant such as
magnesium stearate or sodium dodecyl sulfate and
an excipients, U. S. Patent US 07/773, 183, 1992.
53. J. A. Mccarty. Fast buccal tablet, C. A. Patent CA
2004033 A1, 1990.
54. N. S. Miller, T. P. Johnston. The use of mucoadhesive
polymers in buccal drug delivery, Adv. drug delivery
Rev. 57 (11): 1666-1691 (2005).
55. J. K. Lalla, R. A. Gunancy. Polymer for mucosal
delivery sweeling and mucoadhesive evaluation,
Indian drugs 39 (5): 270-276 (2002).
56. M. A. Hussain, R. J. Reddy, M. Anjum. A
comprehensive review on buccal drug delivery
system, American J. Adv. Drug Delivery 1 (3): 300-
312 (2013).
57. D. L. Wise. Handbook of Pharmaceutical Controlled
Release Technology, CRC press, USA, 2000, pp. 255-
265.
58. D. Tabor. Surface forces and surface interactions, J.
Colloid interface. Sci. 58 (1): 2-13 (1977).
59. M. R. J. Castellanos, H. Zia, C. T. Rhodes.
Mucoadhesive drug delivery systems, Drug Dev. Ind.
Pharm. 19: 143-194 (1993).
60. R. S. Longer, N. A. Peppas. Present and future
applications of biomaterials in controlled drug
delivery systems, Biomaterials 2 (4): 201-214
(1981).
61. S. K. Gupta, I. J. Singhavi, M. Shirsat, G. Karwani, A.
Agrawal, A. Agrawal. Buccal adhesive drug delivery
system: a review, Asian J. Biochem. and Pharm. Res.
(1) 2: 105-114 (2011).
62. A. Gupta, S. Garg, R. K. Khar. Measurement of
bioadhesive strengths of mucoadhesive buccal
tablets: Design of in-vitro assembly, Indian Drugs
30 (4): 152-155 (1992).
63. J. D. Smart. An in vitro assessment of some
mucosaadhesive dosage forms, Int. J. Pharm. 73: 69-
74 (1991).
Gaurav et al., ARPB, 2014; Vol 4 (III) ISSN 2250-0774
(REVIEW ARTICLE)
733 | P a g e w w w . a r p b . i n f o
64. K. P. R. Chowdhary, L. Shrinivas. Mucoadhesive drug
delivery systems, Indian drugs 37 (9): 400-406
(2000).
65. N. Verma, P. Chattopadhay. Polymeric platform for
mucoadhesive buccal drug delivery system: a
review, Int. J. Curr. Pharm. Res. 3 (3): 3-8 (2011).
66. Y. Sudhakar, K. Kuotsu, A. K. Bandyopadhyay. Buccal
bioadhesive drug delivery- a promising option for
orally less efficient drugs, J. Contr. Rel. 114 (1): 15–
40 (2006).